Dr. Bharath Kumar has a post graduate degree in Anesthesiology from the Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh. He completed this with Honors and was awarded the Bronze Medal for academic excellence by PGIMER. He subsequently went on to complete Fellowships in Critical Care from National University Hospital, Singapore and Sunnybrook Health Sciences Centre, Toronto. He has also completed the European Diploma in Intensive Care (EDIC) and is currently working as Senior Consultant at Apollo Main Hospitals and is the Research Lead for the group.

Bharath Kumar holds a MSc. in Clinical Trials from the prestigious London School of Hygiene and Tropical Medicine and is deeply passionate about research in Lower Middle-Income Countries (LMICs). Specifically, he is interested in the establishment and development of research networks for critical care in LMICs and the epidemiology of critical illness in resource limited settings and has established the first national registry of intensive care patients in the country – Indian Registry of IntenSive care (IRIS).

Bharath has served as PI for important trials including the HOPE trial (hydroxychloroquine prophylaxis against SARS-CoV-2 for healthcare workers) and the LOVIT- India trial (intravenous Vitamin C for sepsis). Additionally, he has either served as the country lead or on the steering committee of several trials such as COVID-STEROID 2, Mega-ROX, among others. 

He is currently leading a trial comparing normal saline vs. balanced crystalloids for patients with DKA as well as a trial of steroids in dengue